Agilent Technologies to Acquire BIOVECTRA for $925 Million
Key Highlights Agilent to acquire BIOVECTRA for $925 million. Expands services with sterile fill-finish, pDNA, mRNA, and LNP…
Day: July 29, 2024
9 posts
Elucid Names Kelly Huang, PhD, as New CEO to Lead Commercial Launch
Key Highlights Elucid appoints Kelly Huang, PhD, as new CEO. Huang brings extensive market planning and commercialization expertise.…
Janux Therapeutics Appoints Eric Dobmeier and Natasha Hernday to Board of Directors
Key Highlights Janux Therapeutics appoints Eric Dobmeier and Natasha Hernday to Board of Directors. David Campbell, Ph.D., highlights their experience and leadership as crucial…
Kåre Schultz Joins Hims & Hers Board of Directors
Key Highlights Kåre Schultz brings extensive leadership experience in healthcare. Schultz’s tenure includes roles at Teva Pharmaceutical, Lundbeck, and Novo…
Found Appoints Luca Ranaldi as New CEO to Drive Growth and Innovation
Key Highlights Luca Ranaldi named CEO of Found, effective July 22, 2024. Found serves over 250,000 patients with…
Fuzionaire Theranostics Welcomes New Board Members to Propel Clinical Development
Key Highlights Li Boynton joins Board of Directors with extensive healthcare finance experience. Dr. Klaus Kopka joins Advisory Board with…
Milestone Scientific Secures Medicare Payment for CompuFlo® Epidural System
Key Highlights Medicare Part B payment rate granted for CompuFlo® Epidural System. Coverage includes JL (Delaware, DC, Maryland,…
Together Women’s Health Enters Missouri Market with New Affiliation
Key Highlights Together Women’s Health affiliates with Women’s Health Associates in Missouri. This affiliation adds 11 physicians and…
Loyal Secures $33.5M Series B Financing to Propel Growth
Key Highlights Loyal closes $33.5M Series B financing to expand customer base and product development. Chad Mallory steps down…